Structure

Physi-Chem Properties

Molecular Weight:  442.13
Volume:  427.522
LogP:  4.47
LogD:  1.846
LogS:  -3.228
# Rotatable Bonds:  4
TPSA:  164.75
# H-Bond Aceptor:  9
# H-Bond Donor:  6
# Rings:  4
# Heavy Atoms:  9

MedChem Properties

QED Drug-Likeness Score:  0.203
Synthetic Accessibility Score:  4.049
Fsp3:  0.304
Lipinski Rule-of-5:  Accepted
Pfizer Rule:  Accepted
GSK Rule:  Rejected
BMS Rule:  1
Golden Triangle Rule:  Accepted
Chelating Alert:  0
PAINS Alert:  0

ADMET Properties (ADMETlab2.0)

ADMET: Absorption

Caco-2 Permeability:  -5.599
MDCK Permeability:  5.4864831326995045e-06
Pgp-inhibitor:  0.032
Pgp-substrate:  0.008
Human Intestinal Absorption (HIA):  0.959
20% Bioavailability (F20%):  0.019
30% Bioavailability (F30%):  0.94

ADMET: Distribution

Blood-Brain-Barrier Penetration (BBB):  0.004
Plasma Protein Binding (PPB):  96.58625030517578%
Volume Distribution (VD):  1.03
Pgp-substrate:  6.919801235198975%

ADMET: Metabolism

CYP1A2-inhibitor:  0.517
CYP1A2-substrate:  0.846
CYP2C19-inhibitor:  0.048
CYP2C19-substrate:  0.058
CYP2C9-inhibitor:  0.681
CYP2C9-substrate:  0.736
CYP2D6-inhibitor:  0.079
CYP2D6-substrate:  0.157
CYP3A4-inhibitor:  0.089
CYP3A4-substrate:  0.053

ADMET: Excretion

Clearance (CL):  3.1
Half-life (T1/2):  0.302

ADMET: Toxicity

hERG Blockers:  0.002
Human Hepatotoxicity (H-HT):  0.077
Drug-inuced Liver Injury (DILI):  0.958
AMES Toxicity:  0.741
Rat Oral Acute Toxicity:  0.029
Maximum Recommended Daily Dose:  0.037
Skin Sensitization:  0.712
Carcinogencity:  0.046
Eye Corrosion:  0.003
Eye Irritation:  0.748
Respiratory Toxicity:  0.055

Download Data

Data Type Select
General Info & Identifiers & Properties  
Structure MOL file  
Source Organisms  
Biological Activities  
Similar NPs/Drugs  

  Natural Product: NPC470408

Natural Product ID:  NPC470408
Common Name*:   Methyl (1R,2R,4S)-2,4,5,7,12-Pentahydroxy-6,11-Dioxo-2-Propyl-3,4-Dihydro-1H-Tetracene-1-Carboxylate
IUPAC Name:   methyl (1R,2R,4S)-2,4,5,7,12-pentahydroxy-6,11-dioxo-2-propyl-3,4-dihydro-1H-tetracene-1-carboxylate
Synonyms:  
Standard InCHIKey:  RBVRMUUHLBHOCG-RLAVILMUSA-N
Standard InCHI:  InChI=1S/C23H22O9/c1-3-7-23(31)8-11(25)13-14(17(23)22(30)32-2)21(29)15-16(20(13)28)19(27)12-9(18(15)26)5-4-6-10(12)24/h4-6,11,17,24-25,28-29,31H,3,7-8H2,1-2H3/t11-,17-,23+/m0/s1
SMILES:  CCC[C@@]1(O)C[C@H](O)c2c([C@H]1C(=O)OC)c(O)c1c(c2O)C(=O)c2c(C1=O)cccc2O
Synthetic Gene Cluster:   n.a.
ChEMBL Identifier:   CHEMBL2024358
PubChem CID:   57381725
Chemical Classification**:  
  • CHEMONTID:0000000 [Organic compounds]
    • [CHEMONTID:0002448] Benzenoids
      • [CHEMONTID:0000022] Naphthacenes
        • [CHEMONTID:0000155] Tetracenequinones

*Note: the InCHIKey will be temporarily assigned as the "Common Name" if no IUPAC name or alternative short name is available.
**Note: the Chemical Classification was calculated by NPClassifier Version 1.5. Reference: PMID:34662515.

  Species Source

Organism ID Organism Name Taxonomy Level Family SuperKingdom Isolation Part Collection Location Collection Time Reference
NPO32815 micromonospora sp. Species Micromonosporaceae Bacteria n.a. n.a. n.a. PMID[22250891]
NPO32815 micromonospora sp. Species Micromonosporaceae Bacteria n.a. n.a. n.a. PMID[25375258]
NPO32815 micromonospora sp. Species Micromonosporaceae Bacteria n.a. n.a. n.a. PMID[26444379]
NPO32815 micromonospora sp. Species Micromonosporaceae Bacteria n.a. n.a. n.a. PMID[27813411]
NPO32815 micromonospora sp. Species Micromonosporaceae Bacteria n.a. n.a. n.a. PMID[31794218]

☑ Note for Reference:
In addition to directly collecting NP source organism data from primary literature (where reference will provided as NCBI PMID or DOI links), NPASS also integrated them from below databases:
UNPD: Universal Natural Products Database [PMID: 23638153].
StreptomeDB: a database of streptomycetes natural products [PMID: 33051671].
TM-MC: a database of medicinal materials and chemical compounds in Northeast Asian traditional medicine [PMID: 26156871].
TCM@Taiwan: a Traditional Chinese Medicine database [PMID: 21253603].
TCMID: a Traditional Chinese Medicine database [PMID: 29106634].
TCMSP: The traditional Chinese medicine systems pharmacology database and analysis platform [PMID: 24735618].
HerDing: a herb recommendation system to treat diseases using genes and chemicals [PMID: 26980517].
MetaboLights: a metabolomics database [PMID: 27010336].
FooDB: a database of constituents, chemistry and biology of food species [www.foodb.ca].

  NP Quantity Composition/Concentration

Organism ID NP ID Organism Material Preparation Organism Part NP Quantity (Standard) NP Quantity (Minimum) NP Quantity (Maximum) Quantity Unit Reference

☑ Note for Reference:
In addition to directly collecting NP quantitative data from primary literature (where reference will provided as NCBI PMID or DOI links), NPASS also integrated NP quantitative records for specific NP domains (e.g., NPS from foods or herbs) from domain-specific databases. These databases include:
DUKE: Dr. Duke's Phytochemical and Ethnobotanical Databases.
PHENOL EXPLORER: is the first comprehensive database on polyphenol content in foods [PMID: 24103452], its homepage can be accessed at here.
FooDB: a database of constituents, chemistry and biology of food species [www.foodb.ca].

  Biological Activity

Target ID Target Type Target Name Target Organism Activity Type Activity Relation Value Unit Reference
NPT180 Cell Line HCT-8 Homo sapiens IC50 = 6200.0 nM PMID[556055]

☑ Note for Activity Records:
☉ The quantitative biological activities were primarily integrated from ChEMBL (Version-30) database and were also directly collected from PubMed literature. PubMed PMID was provided as the reference link for each activity record.

  Chemically structural similarity: I. Similar Active Natural Products in NPASS

Top-200 similar NPs were calculated against the active-NP-set (includes 4,3285 NPs with experimentally-derived bioactivity available in NPASS)

Similarity level is defined by Tanimoto coefficient (Tc) between two molecules. Tc lies between [0, 1] where '1' indicates the highest similarity. What is Tanimoto coefficient

●  The left chart: Distribution of similarity level between NPC470408 and all remaining natural products in the NPASS database.
●  The right table: Most similar natural products (Tc>=0.56 or Top200).

Similarity Score Similarity Level Natural Product ID
1.0 High Similarity NPC474824
1.0 High Similarity NPC182921
1.0 High Similarity NPC218870
0.9865 High Similarity NPC474861
0.9527 High Similarity NPC315520
0.9161 High Similarity NPC284495
0.915 High Similarity NPC66029
0.9 High Similarity NPC314437
0.8933 High Similarity NPC471683
0.8889 High Similarity NPC205766
0.8874 High Similarity NPC285122
0.8859 High Similarity NPC135524
0.8851 High Similarity NPC315578
0.8816 High Similarity NPC119767
0.8812 High Similarity NPC478022
0.8812 High Similarity NPC478020
0.8808 High Similarity NPC170055
0.88 High Similarity NPC471682
0.8792 High Similarity NPC204045
0.8792 High Similarity NPC305845
0.8784 High Similarity NPC26924
0.8782 High Similarity NPC3449
0.8758 High Similarity NPC94781
0.875 High Similarity NPC147250
0.8742 High Similarity NPC300684
0.8742 High Similarity NPC244691
0.8742 High Similarity NPC471906
0.8742 High Similarity NPC48130
0.8742 High Similarity NPC84568
0.8742 High Similarity NPC218866
0.8734 High Similarity NPC324736
0.8733 High Similarity NPC85310
0.8733 High Similarity NPC474961
0.8733 High Similarity NPC474300
0.8733 High Similarity NPC469520
0.8733 High Similarity NPC257644
0.8725 High Similarity NPC169452
0.8725 High Similarity NPC181560
0.8718 High Similarity NPC474622
0.8718 High Similarity NPC205172
0.8718 High Similarity NPC209393
0.8718 High Similarity NPC312482
0.8718 High Similarity NPC474621
0.8701 High Similarity NPC477221
0.8701 High Similarity NPC44378
0.8701 High Similarity NPC280753
0.8684 High Similarity NPC34482
0.8675 High Similarity NPC476473
0.8671 High Similarity NPC208651
0.8671 High Similarity NPC206641
0.8671 High Similarity NPC317580
0.8667 High Similarity NPC257003
0.8662 High Similarity NPC192219
0.8662 High Similarity NPC82190
0.8662 High Similarity NPC318270
0.8662 High Similarity NPC174599
0.8659 High Similarity NPC477836
0.8658 High Similarity NPC242994
0.8658 High Similarity NPC143438
0.8658 High Similarity NPC138099
0.8658 High Similarity NPC190457
0.8654 High Similarity NPC474533
0.8654 High Similarity NPC474534
0.8649 High Similarity NPC245923
0.8649 High Similarity NPC305060
0.8636 High Similarity NPC112816
0.8627 High Similarity NPC470570
0.8627 High Similarity NPC300540
0.8618 High Similarity NPC48762
0.8618 High Similarity NPC10764
0.8618 High Similarity NPC193703
0.8618 High Similarity NPC21599
0.8616 High Similarity NPC326084
0.8609 High Similarity NPC193555
0.8608 High Similarity NPC148323
0.8608 High Similarity NPC283480
0.8608 High Similarity NPC478027
0.86 High Similarity NPC37992
0.86 High Similarity NPC32749
0.86 High Similarity NPC220496
0.86 High Similarity NPC147542
0.86 High Similarity NPC327916
0.86 High Similarity NPC42262
0.86 High Similarity NPC241349
0.86 High Similarity NPC225243
0.8598 High Similarity NPC478021
0.8591 High Similarity NPC4214
0.8591 High Similarity NPC13715
0.859 High Similarity NPC470569
0.859 High Similarity NPC477276
0.8589 High Similarity NPC107009
0.8589 High Similarity NPC76647
0.8581 High Similarity NPC272268
0.8581 High Similarity NPC474813
0.8581 High Similarity NPC120171
0.8581 High Similarity NPC155211
0.858 High Similarity NPC71390
0.8571 High Similarity NPC290194
0.8571 High Similarity NPC52161
0.8571 High Similarity NPC187934
0.8571 High Similarity NPC37709
0.8571 High Similarity NPC315772
0.8571 High Similarity NPC162751
0.8571 High Similarity NPC97637
0.8562 High Similarity NPC70622
0.8562 High Similarity NPC475449
0.8553 High Similarity NPC66593
0.8545 High Similarity NPC473113
0.8545 High Similarity NPC294501
0.8544 High Similarity NPC314257
0.8544 High Similarity NPC266469
0.8544 High Similarity NPC66508
0.8544 High Similarity NPC226656
0.8543 High Similarity NPC106519
0.8543 High Similarity NPC246638
0.8543 High Similarity NPC187843
0.8543 High Similarity NPC91019
0.8543 High Similarity NPC290550
0.8533 High Similarity NPC471602
0.8533 High Similarity NPC256463
0.8533 High Similarity NPC476477
0.8533 High Similarity NPC306835
0.8533 High Similarity NPC299405
0.8533 High Similarity NPC216312
0.8533 High Similarity NPC111422
0.8533 High Similarity NPC29771
0.8528 High Similarity NPC477835
0.8526 High Similarity NPC470568
0.8526 High Similarity NPC290954
0.8526 High Similarity NPC255641
0.8526 High Similarity NPC147735
0.8526 High Similarity NPC294646
0.8523 High Similarity NPC53414
0.8523 High Similarity NPC53206
0.8523 High Similarity NPC471905
0.8516 High Similarity NPC106524
0.8516 High Similarity NPC290695
0.8514 High Similarity NPC161632
0.8514 High Similarity NPC80035
0.8506 High Similarity NPC136878
0.8503 High Similarity NPC52407
0.8497 Intermediate Similarity NPC79627
0.8493 Intermediate Similarity NPC205992
0.8487 Intermediate Similarity NPC239136
0.8487 Intermediate Similarity NPC137649
0.8487 Intermediate Similarity NPC19631
0.8477 Intermediate Similarity NPC183345
0.8477 Intermediate Similarity NPC168471
0.8476 Intermediate Similarity NPC234497
0.8476 Intermediate Similarity NPC472058
0.8476 Intermediate Similarity NPC324522
0.8476 Intermediate Similarity NPC105414
0.8476 Intermediate Similarity NPC470341
0.8471 Intermediate Similarity NPC205918
0.8456 Intermediate Similarity NPC254847
0.8456 Intermediate Similarity NPC118919
0.8452 Intermediate Similarity NPC478018
0.8447 Intermediate Similarity NPC476506
0.8447 Intermediate Similarity NPC472055
0.8446 Intermediate Similarity NPC288089
0.8442 Intermediate Similarity NPC478019
0.8438 Intermediate Similarity NPC263483
0.8435 Intermediate Similarity NPC110609
0.8435 Intermediate Similarity NPC242358
0.8435 Intermediate Similarity NPC246693
0.8431 Intermediate Similarity NPC174905
0.8431 Intermediate Similarity NPC474203
0.8431 Intermediate Similarity NPC451542
0.8431 Intermediate Similarity NPC295712
0.8431 Intermediate Similarity NPC296752
0.8431 Intermediate Similarity NPC313047
0.8431 Intermediate Similarity NPC293545
0.8428 Intermediate Similarity NPC68727
0.8425 Intermediate Similarity NPC199253
0.8425 Intermediate Similarity NPC31799
0.8425 Intermediate Similarity NPC136588
0.8421 Intermediate Similarity NPC471444
0.8418 Intermediate Similarity NPC478220
0.8415 Intermediate Similarity NPC30027
0.8411 Intermediate Similarity NPC295339
0.84 Intermediate Similarity NPC62272
0.8397 Intermediate Similarity NPC172329
0.8397 Intermediate Similarity NPC142846
0.8397 Intermediate Similarity NPC2569
0.8397 Intermediate Similarity NPC470479
0.8395 Intermediate Similarity NPC472261
0.8389 Intermediate Similarity NPC283088
0.8387 Intermediate Similarity NPC110882
0.8387 Intermediate Similarity NPC63918
0.8387 Intermediate Similarity NPC271944
0.8387 Intermediate Similarity NPC143685
0.8387 Intermediate Similarity NPC85393
0.8387 Intermediate Similarity NPC120536
0.8385 Intermediate Similarity NPC314795
0.8385 Intermediate Similarity NPC470339
0.8385 Intermediate Similarity NPC186113
0.8383 Intermediate Similarity NPC472054
0.8378 Intermediate Similarity NPC314048
0.8378 Intermediate Similarity NPC225051
0.8378 Intermediate Similarity NPC115458

  Chemically structural similarity: II. Similar Clinical/Approved Drugs

Similarity level is defined by Tanimoto coefficient (Tc) between two molecules.

●  The left chart: Distribution of similarity level between NPC470408 and all drugs/candidates.
●  The right table: Most similar clinical/approved drugs (Tc>=0.56 or Top200).

Similarity Score Similarity Level Drug ID Developmental Stage
0.848 Intermediate Similarity NPD7879 Clinical (unspecified phase)
0.8456 Intermediate Similarity NPD1509 Clinical (unspecified phase)
0.84 Intermediate Similarity NPD5404 Approved
0.84 Intermediate Similarity NPD5408 Approved
0.84 Intermediate Similarity NPD5406 Approved
0.84 Intermediate Similarity NPD5405 Approved
0.8377 Intermediate Similarity NPD7390 Discontinued
0.8303 Intermediate Similarity NPD7473 Discontinued
0.8246 Intermediate Similarity NPD8150 Discontinued
0.8232 Intermediate Similarity NPD6232 Discontinued
0.8113 Intermediate Similarity NPD3226 Approved
0.8082 Intermediate Similarity NPD1470 Approved
0.8068 Intermediate Similarity NPD6534 Approved
0.8068 Intermediate Similarity NPD6535 Approved
0.8061 Intermediate Similarity NPD6959 Discontinued
0.8025 Intermediate Similarity NPD7819 Suspended
0.8011 Intermediate Similarity NPD7435 Discontinued
0.7988 Intermediate Similarity NPD5844 Phase 1
0.7975 Intermediate Similarity NPD7422 Clinical (unspecified phase)
0.7944 Intermediate Similarity NPD6781 Approved
0.7944 Intermediate Similarity NPD6779 Approved
0.7944 Intermediate Similarity NPD6782 Approved
0.7944 Intermediate Similarity NPD6780 Approved
0.7944 Intermediate Similarity NPD6778 Approved
0.7944 Intermediate Similarity NPD6777 Approved
0.7944 Intermediate Similarity NPD6776 Approved
0.7933 Intermediate Similarity NPD7700 Phase 2
0.7933 Intermediate Similarity NPD7699 Phase 2
0.7922 Intermediate Similarity NPD2935 Discontinued
0.7869 Intermediate Similarity NPD8319 Approved
0.7869 Intermediate Similarity NPD8320 Phase 1
0.7862 Intermediate Similarity NPD2532 Approved
0.7862 Intermediate Similarity NPD2534 Approved
0.7862 Intermediate Similarity NPD2533 Approved
0.7861 Intermediate Similarity NPD8313 Approved
0.7861 Intermediate Similarity NPD8312 Approved
0.7841 Intermediate Similarity NPD8397 Clinical (unspecified phase)
0.784 Intermediate Similarity NPD4380 Phase 2
0.7814 Intermediate Similarity NPD7698 Approved
0.7814 Intermediate Similarity NPD7696 Phase 3
0.7814 Intermediate Similarity NPD7697 Approved
0.7808 Intermediate Similarity NPD1201 Approved
0.7791 Intermediate Similarity NPD7411 Suspended
0.7772 Intermediate Similarity NPD7870 Phase 2
0.7772 Intermediate Similarity NPD7871 Phase 2
0.7758 Intermediate Similarity NPD8443 Clinical (unspecified phase)
0.7754 Intermediate Similarity NPD7875 Clinical (unspecified phase)
0.7754 Intermediate Similarity NPD7874 Approved
0.7709 Intermediate Similarity NPD6212 Phase 3
0.7709 Intermediate Similarity NPD6214 Clinical (unspecified phase)
0.7709 Intermediate Similarity NPD6213 Phase 3
0.7706 Intermediate Similarity NPD7852 Clinical (unspecified phase)
0.7669 Intermediate Similarity NPD5808 Clinical (unspecified phase)
0.7665 Intermediate Similarity NPD7075 Discontinued
0.7651 Intermediate Similarity NPD5402 Approved
0.7647 Intermediate Similarity NPD7701 Phase 2
0.7643 Intermediate Similarity NPD2346 Discontinued
0.764 Intermediate Similarity NPD7410 Clinical (unspecified phase)
0.7619 Intermediate Similarity NPD7801 Approved
0.7605 Intermediate Similarity NPD7768 Phase 2
0.7595 Intermediate Similarity NPD970 Clinical (unspecified phase)
0.759 Intermediate Similarity NPD2393 Clinical (unspecified phase)
0.7574 Intermediate Similarity NPD5494 Approved
0.7568 Intermediate Similarity NPD6823 Phase 2
0.7562 Intermediate Similarity NPD6190 Approved
0.756 Intermediate Similarity NPD3749 Approved
0.754 Intermediate Similarity NPD7211 Clinical (unspecified phase)
0.7531 Intermediate Similarity NPD4378 Clinical (unspecified phase)
0.753 Intermediate Similarity NPD6801 Discontinued
0.7516 Intermediate Similarity NPD1510 Phase 2
0.75 Intermediate Similarity NPD7003 Approved
0.75 Intermediate Similarity NPD1607 Approved
0.75 Intermediate Similarity NPD4868 Clinical (unspecified phase)
0.7485 Intermediate Similarity NPD7096 Clinical (unspecified phase)
0.7484 Intermediate Similarity NPD943 Approved
0.7468 Intermediate Similarity NPD3764 Approved
0.7456 Intermediate Similarity NPD4381 Clinical (unspecified phase)
0.7455 Intermediate Similarity NPD7458 Discontinued
0.7443 Intermediate Similarity NPD6559 Discontinued
0.7438 Intermediate Similarity NPD7421 Clinical (unspecified phase)
0.743 Intermediate Similarity NPD8434 Phase 2
0.7423 Intermediate Similarity NPD7004 Clinical (unspecified phase)
0.7421 Intermediate Similarity NPD8151 Discontinued
0.7407 Intermediate Similarity NPD3300 Phase 2
0.7401 Intermediate Similarity NPD4338 Clinical (unspecified phase)
0.7399 Intermediate Similarity NPD6167 Clinical (unspecified phase)
0.7399 Intermediate Similarity NPD6166 Phase 2
0.7399 Intermediate Similarity NPD6168 Clinical (unspecified phase)
0.7391 Intermediate Similarity NPD3750 Approved
0.7391 Intermediate Similarity NPD1878 Clinical (unspecified phase)
0.7381 Intermediate Similarity NPD2801 Approved
0.7375 Intermediate Similarity NPD1549 Phase 2
0.7374 Intermediate Similarity NPD8055 Clinical (unspecified phase)
0.7372 Intermediate Similarity NPD1240 Approved
0.7368 Intermediate Similarity NPD1164 Approved
0.736 Intermediate Similarity NPD8155 Clinical (unspecified phase)
0.7321 Intermediate Similarity NPD1934 Approved
0.7321 Intermediate Similarity NPD37 Approved
0.7314 Intermediate Similarity NPD3751 Discontinued
0.7314 Intermediate Similarity NPD3818 Discontinued
0.7312 Intermediate Similarity NPD1552 Clinical (unspecified phase)
0.7312 Intermediate Similarity NPD1550 Clinical (unspecified phase)
0.7305 Intermediate Similarity NPD6599 Discontinued
0.7296 Intermediate Similarity NPD2799 Discontinued
0.7296 Intermediate Similarity NPD651 Clinical (unspecified phase)
0.7288 Intermediate Similarity NPD7993 Clinical (unspecified phase)
0.7284 Intermediate Similarity NPD4628 Phase 3
0.7283 Intermediate Similarity NPD5710 Approved
0.7283 Intermediate Similarity NPD5711 Approved
0.7279 Intermediate Similarity NPD405 Clinical (unspecified phase)
0.7273 Intermediate Similarity NPD7804 Clinical (unspecified phase)
0.7273 Intermediate Similarity NPD6273 Approved
0.7254 Intermediate Similarity NPD7783 Phase 2
0.7254 Intermediate Similarity NPD7782 Clinical (unspecified phase)
0.725 Intermediate Similarity NPD2796 Approved
0.725 Intermediate Similarity NPD1551 Phase 2
0.7235 Intermediate Similarity NPD3817 Phase 2
0.7232 Intermediate Similarity NPD7074 Phase 3
0.7229 Intermediate Similarity NPD5403 Approved
0.7216 Intermediate Similarity NPD7177 Discontinued
0.7193 Intermediate Similarity NPD4966 Approved
0.7193 Intermediate Similarity NPD4965 Approved
0.7193 Intermediate Similarity NPD4967 Phase 2
0.7191 Intermediate Similarity NPD5953 Discontinued
0.7188 Intermediate Similarity NPD3299 Clinical (unspecified phase)
0.7184 Intermediate Similarity NPD3787 Discontinued
0.7178 Intermediate Similarity NPD8166 Discontinued
0.7178 Intermediate Similarity NPD6398 Clinical (unspecified phase)
0.7175 Intermediate Similarity NPD7054 Approved
0.7152 Intermediate Similarity NPD6799 Approved
0.7135 Intermediate Similarity NPD7472 Approved
0.7134 Intermediate Similarity NPD2313 Discontinued
0.7111 Intermediate Similarity NPD36 Approved
0.7111 Intermediate Similarity NPD4954 Approved
0.7111 Intermediate Similarity NPD5034 Approved
0.7111 Intermediate Similarity NPD5026 Approved
0.7111 Intermediate Similarity NPD5028 Approved
0.7111 Intermediate Similarity NPD4955 Approved
0.711 Intermediate Similarity NPD6234 Discontinued
0.7108 Intermediate Similarity NPD5401 Approved
0.7107 Intermediate Similarity NPD230 Phase 1
0.7095 Intermediate Similarity NPD6797 Phase 2
0.7093 Intermediate Similarity NPD3882 Suspended
0.7091 Intermediate Similarity NPD7236 Approved
0.7089 Intermediate Similarity NPD6663 Approved
0.7083 Intermediate Similarity NPD7239 Suspended
0.7081 Intermediate Similarity NPD3748 Approved
0.7076 Intermediate Similarity NPD1465 Phase 2
0.707 Intermediate Similarity NPD7008 Discontinued
0.7056 Intermediate Similarity NPD5030 Phase 2
0.7056 Intermediate Similarity NPD7251 Discontinued
0.7051 Intermediate Similarity NPD5736 Approved
0.7049 Intermediate Similarity NPD5038 Approved
0.7049 Intermediate Similarity NPD5037 Approved
0.7048 Intermediate Similarity NPD1511 Approved
0.7047 Intermediate Similarity NPD9493 Approved
0.7037 Intermediate Similarity NPD6099 Approved
0.7037 Intermediate Similarity NPD8285 Discontinued
0.7037 Intermediate Similarity NPD6100 Approved
0.7027 Intermediate Similarity NPD5951 Approved
0.7024 Intermediate Similarity NPD920 Approved
0.7022 Intermediate Similarity NPD7228 Approved
0.7017 Intermediate Similarity NPD7808 Phase 3
0.701 Intermediate Similarity NPD8058 Clinical (unspecified phase)
0.701 Intermediate Similarity NPD8059 Phase 3
0.6995 Remote Similarity NPD5036 Approved
0.6989 Remote Similarity NPD7229 Phase 3
0.6987 Remote Similarity NPD6007 Clinical (unspecified phase)
0.6987 Remote Similarity NPD2798 Approved
0.6983 Remote Similarity NPD7286 Phase 2
0.6978 Remote Similarity NPD5035 Approved
0.6977 Remote Similarity NPD5760 Phase 2
0.6977 Remote Similarity NPD5761 Phase 2
0.6975 Remote Similarity NPD7033 Discontinued
0.6974 Remote Similarity NPD3019 Approved
0.697 Remote Similarity NPD3400 Discontinued
0.6968 Remote Similarity NPD1283 Approved
0.6964 Remote Similarity NPD1512 Approved
0.6961 Remote Similarity NPD5039 Approved
0.6959 Remote Similarity NPD6973 Clinical (unspecified phase)
0.6957 Remote Similarity NPD6651 Approved
0.6954 Remote Similarity NPD9545 Approved
0.6936 Remote Similarity NPD8438 Clinical (unspecified phase)
0.6927 Remote Similarity NPD7799 Discontinued
0.6923 Remote Similarity NPD6980 Clinical (unspecified phase)
0.6918 Remote Similarity NPD1699 Clinical (unspecified phase)
0.6909 Remote Similarity NPD2800 Approved
0.6905 Remote Similarity NPD642 Clinical (unspecified phase)
0.6899 Remote Similarity NPD6832 Phase 2
0.6892 Remote Similarity NPD7635 Approved
0.689 Remote Similarity NPD2343 Clinical (unspecified phase)
0.689 Remote Similarity NPD2344 Approved
0.6882 Remote Similarity NPD8360 Approved
0.6882 Remote Similarity NPD8361 Approved
0.6871 Remote Similarity NPD4308 Phase 3
0.6868 Remote Similarity NPD7685 Pre-registration
0.6863 Remote Similarity NPD2932 Approved
0.6863 Remote Similarity NPD7163 Clinical (unspecified phase)
0.6855 Remote Similarity NPD5952 Clinical (unspecified phase)
0.6851 Remote Similarity NPD4956 Approved

  Bioactivity similarity: Similar Natural Products in NPASS

Bioactivity similarity was calculated based on bioactivity descriptors of compounds. The bioactivity descriptors were calculated by a recently developed AI algorithm Chemical Checker (CC) [Nature Biotechnology, 38:1087–1096, 2020; Nature Communications, 12:3932, 2021], which evaluated bioactivity similarities at five levels:
A: chemistry similarity;
B: biological targets similarity;
C: networks similarity;
D: cell-based bioactivity similarity;
E: similarity based on clinical data.

Those 5 categories of CC bioactivity descriptors were calculated and then subjected to manifold projection using UMAP algorithm, to project all NPs on a 2-Dimensional space. The current NP was highlighted with a small circle in the 2-D map. Below figures: left-to-right, A-to-E.

A: chemistry similarity
B: biological targets similarity
C: networks similarity
D: cell-based bioactivity similarity
E: similarity based on clinical data